Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

How Time Spent on Rituximab Infusion Impacts Patient Satisfaction, Stress, Employment, and Caregiver Burden

Maxine D Fisher, PhD, Christopher Wallick, PharmD, Paul J Miller, PhD, Mark S Walker, PhD, Stephen Lash, PharmD, Keith L Dawson, DNP, Carolina M Reyes, PhD

Blood (2017) 130 (Supplement 1): 5666.

https://doi.org/10.1182/blood.V130.Suppl_1.5666.5666

Published: 2017

Journal Articles

The Ultra-Low-Molecular-Weight Heparin Semuloparin for Prevention of Venous Thromboembolism In Patients Undergoing Major Abdominal Surgery

Ajay K. Kakkar, MBBS, PhD, Giancarlo Agnelli, William D. Fisher, MD, Daniel George, Patrick Mouret, Michael R. Lassen, MD, Patrick Mismetti, Judith Murphy, Alexander G.G. Turpie

Blood (2010) 116 (21): 188.

https://doi.org/10.1182/blood.V116.21.188.188

Published: 2010

Journal Articles

Phase II Dose-Finding Study with TAK-442, An Oral Factor Xa Inhibitor, in Patients Undergoing Elective Knee Arthroplasty.

Jeffrey I. Weitz, MD, FACP, FRCP, Charlie Cao, Ph.D., Bengt Eriksson, MD, William D. Fisher, MD, Stuart Kupfer, MD, Gary E Raskob, PhD, Jeffrey Spaeder, MD, Alexander GG Turpie, MD

Blood (2009) 114 (22): 170.

https://doi.org/10.1182/blood.V114.22.170.170

Published: 2009

Journal Articles

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1

Robert C. Carlisle, Ying Di, Anna M. Cerny, Andreas F.-P. Sonnen, Robert B. Sim, Nicola K. Green, Vladimir Subr, Karel Ulbrich, Robert J. C. Gilbert, Kerry D. Fisher, Robert W. Finberg, Leonard W. Seymour

Blood (2009) 113 (9): 1909–1918.

https://doi.org/10.1182/blood-2008-09-178459

Published: 2009

Includes: Supplemental data

Journal Articles

Thromboprophylaxis after Orthopaedic Surgery with an Oral, Direct Factor Xa Inhibitor: Pooled Results of Two Phase Iib Clinical Trials.

Alexander G.G. Turpie, MD, Kenneth Alan Bauer, MD, Lars Borris, MD, Ola E. Dahl, MD, PhD, William D. Fisher, MD, Michael Gent, MD, PhD, Sylvia Haas, MD, Menno V. Huisman, MD, PhD, Ajay K. Kakkar, MD, PhD, Peter Kälebo, MD, PhD, Louis M. Kwong, MD, Martin Homering, PhD, Frank Misselwitz, MD, PhD, Bengt I. Eriksson, MD, PhD

Blood (2005) 106 (11): 277.

https://doi.org/10.1182/blood.V106.11.277.277

Published: 2005

Journal Articles

Study of Treatment Patterns and Consequences of Immune Thrombocytopenic Purpura (ITP).

Maxine D. Fisher, PhD, Grace Yang, MPA, Lauren P. Burawski, MA, Kelly M. Grotzinger, PhD, MBA, Andrew B. Provan, MD, John J. Barron, PharmD

Blood (2005) 106 (11): 5593.

https://doi.org/10.1182/blood.V106.11.5593.5593

Published: 2005

Journal Articles

Reduced invasion and growth of Plasmodium falciparum into elliptocytic red blood cells with a combined deficiency of protein 4.1, glycophorin C, and p55

AH Chishti, J Palek, D Fisher, GJ Maalouf, SC Liu

Blood (1996) 87 (8): 3462–3469.

https://doi.org/10.1182/blood.V87.8.3462.bloodjournal8783462

Published: 1996

Journal Articles

Phosphorylation of protein 4.1 in Plasmodium falciparum-infected human red blood cells

AH Chishti, GJ Maalouf, S Marfatia, J Palek, W Wang, D Fisher, SC Liu

Blood (1994) 83 (11): 3339–3345.

https://doi.org/10.1182/blood.V83.11.3339.3339

Published: 1994

NARROW

How Time Spent on Rituximab Infusion Impacts Patient Satisfaction, Stress, Employment, and Caregiver Burden

The Ultra-Low-Molecular-Weight Heparin Semuloparin for Prevention of Venous Thromboembolism In Patients Undergoing Major Abdominal Surgery

Phase II Dose-Finding Study with TAK-442, An Oral Factor Xa Inhibitor, in Patients Undergoing Elective Knee Arthroplasty.

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1

Thromboprophylaxis after Orthopaedic Surgery with an Oral, Direct Factor Xa Inhibitor: Pooled Results of Two Phase Iib Clinical Trials.

Study of Treatment Patterns and Consequences of Immune Thrombocytopenic Purpura (ITP).

Reduced invasion and growth of Plasmodium falciparum into elliptocytic red blood cells with a combined deficiency of protein 4.1, glycophorin C, and p55

Phosphorylation of protein 4.1 in Plasmodium falciparum-infected human red blood cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only